NCT00006376View on ClinicalTrials.gov

R115777 in Treating Patients With Advanced Bladder Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2000

Study Completion Date

May 31, 2005

Conditions
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Interventions
DRUG

chemotherapy

DRUG

tipifarnib

Trial Locations (2)

94143-0128

UCSF Cancer Center and Cancer Research Institute, San Francisco

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT00006376 - R115777 in Treating Patients With Advanced Bladder Cancer | Biotech Hunter | Biotech Hunter